Role of antibodies to human papillomavirus 16 in prostate cancer: A seroscreening by peptide microarray
Evidence is accumulating in estimating the potential role of human papillomavirus infection in prostate carcinogenesis. However, the results remain inconclusive. We measured the serostatus of antibodies to one of the high-risk human papillomaviruses, human papillomavirus 16, with a newly developed p...
Saved in:
| Main Authors: | Xiaojun Zhao, Zheng Zhou, Ye Chen, Wen Chen, Hongwei Ma, Jinxian Pu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2017-05-01
|
| Series: | Tumor Biology |
| Online Access: | https://doi.org/10.1177/1010428317698371 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Virtual screening of antiviral peptides as novel blockers of human papillomavirus 16
by: H. Al-Madhagi
Published: (2024-10-01) -
Scoping review of the applications of peptide microarrays on the fight against human infections.
by: Arthur Vengesai, et al.
Published: (2022-01-01) -
Quantifying antibody binding on protein microarrays using microarray nonlinear calibration
by: Xiaobo Yu, et al.
Published: (2013-05-01) -
The role of herpes and human papillomavirus infection in prostate and bladder carcinogenesis
by: L. M. Mikhaleva, et al.
Published: (2022-01-01) -
Serum Antibodies Against the E5 Oncoprotein from Human Papillomavirus Type 16 Are Inversely Associated with the Infection and the Degree of Cervical Lesions
by: Azucena Salazar-Piña, et al.
Published: (2024-11-01)